Literature DB >> 27638836

Cryptococcus neoformans population diversity and clinical outcomes of HIV-associated cryptococcal meningitis patients in Zimbabwe.

Tinashe K Nyazika1,2,3, Ferry Hagen2, Tendai Machiridza4, Melody Kutepa5, Faith Masanganise5, Marijke Hendrickx6, Teun Boekhout7, Tricia Magombei-Majinjiwa1, Nonthokozo Siziba1, Nyasha Chin'ombe1, Kudzanai Mateveke8, Jacques F Meis2,9, Valerie J Robertson1.   

Abstract

HIV and cryptococcal meningitis co-infection is a major public health problem in most developing countries. Cryptococcus neoformans sensu stricto is responsible for the majority of HIV-associated cryptococcosis cases in sub-Saharan Africa. Despite the available information, little is known about cryptococcal population diversity and its association with clinical outcomes in patients with HIV-associated cryptococcal meningitis in sub-Saharan Africa. In a prospective cohort, we investigated the prevalence and clinical outcome of Cryptococcusneoformans sensu stricto meningitis among HIV-infected patients in Harare, Zimbabwe, and compared the genotypic diversity of the isolates with those collected from other parts of Africa. Molecular typing was done using amplified fragment length polymorphism genotyping and microsatellite typing. The majority of patients with HIV-associated Cryptococcusneoformans sensu stricto meningitis in this cohort were males (n=33/55; 60.0 %). The predominant Cryptococcus neoformans sensu stricto genotype among the Zimbabwean isolates was genotype AFLP1/VNI (n=40; 72.7 %), followed by AFLP1A/VNB/VNII (n=8; 14.6 %), and AFLP1B/VNII was the least isolated (n=7; 12.7 %). Most of the isolates were mating-type α (n=51; 92.7 %), and only four (7.3 %) were mating-type a. Overall in-hospital mortality was 55.6 % (n=30), and no difference between infecting genotype and clinical outcome of patient (P=0.73) or CD4+ counts (P=0.79) was observed. Zimbabwean Cryptococcusneoformans sensu stricto genotypes demonstrated a high level of genetic diversity by microsatellite typing, and 51 genotypes within the main molecular types AFLP1/VNI, AFLP1A/VNB/VNII and AFLP1B/VNII were identified. This study demonstrates that Cryptococcusneoformans sensu stricto in Zimbabwe has a high level of genetic diversity when compared to other regional isolates.

Entities:  

Mesh:

Year:  2016        PMID: 27638836     DOI: 10.1099/jmm.0.000354

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

Review 1.  The antifungal pipeline: a reality check.

Authors:  John R Perfect
Journal:  Nat Rev Drug Discov       Date:  2017-05-12       Impact factor: 84.694

2.  The Mouse Inhalation Model of Cryptococcus neoformans Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence.

Authors:  Liliane Mukaremera; Tami R McDonald; Judith N Nielsen; Christopher J Molenaar; Andrew Akampurira; Charlotte Schutz; Kabanda Taseera; Conrad Muzoora; Graeme Meintjes; David B Meya; David R Boulware; Kirsten Nielsen
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

3.  Cryptococcus neoformans-astrocyte interactions: effect on fungal blood brain barrier disruption, brain invasion, and meningitis progression.

Authors:  Yeon Hwa Woo; Luis R Martinez
Journal:  Crit Rev Microbiol       Date:  2021-01-21       Impact factor: 7.624

4.  Comparison and Correlation of Magnetic Resonance Imaging and Clinical Severity in Nonhuman Immunodeficiency Virus Patients with Cryptococcal Infection of Central Nervous System.

Authors:  Xue-Qin Li; Shuang Xia; Jian-Song Ji; Yong-Hua Tang; Mei-Zhu Zheng; Yong-Mei Li; Fei Shan; Zhi-Yan Lu; Jian Wang; Jin-Kang Liu; Hui-Juan Zhang; Yu-Xin Shi; Hong-Jun Li
Journal:  Chin Med J (Engl)       Date:  2018-12-20       Impact factor: 2.628

5.  First Isolation, Antifungal Susceptibility, and Molecular Characterization of Cryptococcus neoformans from the Environment in Croatia.

Authors:  Donjeta Pllana-Hajdari; Massimo Cogliati; Ljiljana Čičmak; Sanja Pleško; Emilija Mlinarić-Missoni; Ivana Mareković
Journal:  J Fungi (Basel)       Date:  2019-10-12

Review 6.  Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co-infection.

Authors:  Samuel Okurut; David R Boulware; Joseph Olobo; David B Meya
Journal:  Mycoses       Date:  2020-06-19       Impact factor: 4.377

7.  A new humanized antibody is effective against pathogenic fungi in vitro.

Authors:  Tomas Di Mambro; Tania Vanzolini; Pierpaolo Bruscolini; Sergio Perez-Gaviro; Emanuele Marra; Giuseppe Roscilli; Marzia Bianchi; Alessandra Fraternale; Giuditta Fiorella Schiavano; Barbara Canonico; Mauro Magnani
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

8.  Phenotypic Variability Correlates with Clinical Outcome in Cryptococcus Isolates Obtained from Botswanan HIV/AIDS Patients.

Authors:  Kenya E Fernandes; Adam Brockway; Miriam Haverkamp; Christina A Cuomo; Floris van Ogtrop; John R Perfect; Dee A Carter
Journal:  mBio       Date:  2018-10-23       Impact factor: 7.867

9.  Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Mark W Tenforde; Alida M Gertz; David S Lawrence; Nicola K Wills; Brandon L Guthrie; Carey Farquhar; Joseph N Jarvis
Journal:  J Int AIDS Soc       Date:  2020-01       Impact factor: 5.396

10.  Targeting Methionine Synthase in a Fungal Pathogen Causes a Metabolic Imbalance That Impacts Cell Energetics, Growth, and Virulence.

Authors:  Jennifer Scott; Monica Sueiro-Olivares; Benjamin P Thornton; Rebecca A Owens; Howbeer Muhamadali; Rachael Fortune-Grant; Darren Thomson; Riba Thomas; Katherine Hollywood; Sean Doyle; Royston Goodacre; Lydia Tabernero; Elaine Bignell; Jorge Amich
Journal:  mBio       Date:  2020-10-13       Impact factor: 7.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.